Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Change in Accured Expenses (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Change in Accured Expenses data on record, last reported at -$118000.0 in Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 84.58% year-over-year to -$118000.0; the TTM value through Dec 2025 reached -$3.6 million, down 939.19%, while the annual FY2025 figure was -$3.6 million, 939.19% down from the prior year.
  • Change in Accured Expenses reached -$118000.0 in Q4 2025 per SGHT's latest filing, down from $965000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.7 million in Q2 2022 and bottomed at -$4.4 million in Q2 2025.
  • Average Change in Accured Expenses over 5 years is -$263800.0, with a median of -$253000.0 recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: plummeted 1381.25% in 2021, then skyrocketed 576.31% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $1.3 million in 2021, then tumbled by 147.59% to -$642000.0 in 2022, then plummeted by 328.97% to -$2.8 million in 2023, then skyrocketed by 72.22% to -$765000.0 in 2024, then surged by 84.58% to -$118000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$118000.0 in Q4 2025, $965000.0 in Q3 2025, and -$4.4 million in Q2 2025.